NGS-based RNA-Sequencing Market Size, Top Share And Forecast to 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global NGS-based RNA-Sequencing Market Size Analysis

Global NGS-based RNA-Sequencing Market Introduction
By Product and Service
1. Introduction
  1. Product and Service By Value
2. Sample Preparation Products
  1. By Value
3. Sequencing Platforms and Consumables
  1. By Value
4. Sequencing Services
  1. By Value
5. Data Analysis, Storage, and Management
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sequencing by Synthesis (SBS)
  1. By Value
3. Ion Semiconductor Sequencing
  1. By Value
4. Single-molecule Real-time Sequencing (SMRT)
  1. By Value
5. Nanopore Sequencing
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Expression Profiling Analysis
  1. By Value
3. Small RNA Sequencing
  1. By Value
4. De Novo Transcriptome Assembly
  1. By Value
5. Variant Calling and Transcriptome Epigenetics
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Research and Academia
  1. By Value
3. Hospitals and Clinics
  1. By Value
4. Pharmaceutical and Biotechnology Companies
  1. By Value

North America Market Analysis

Introduction
By Product and Service
1. Introduction
  1. Product and Service By Value
2. Sample Preparation Products
  1. By Value
3. Sequencing Platforms and Consumables
  1. By Value
4. Sequencing Services
  1. By Value
5. Data Analysis, Storage, and Management
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sequencing by Synthesis (SBS)
  1. By Value
3. Ion Semiconductor Sequencing
  1. By Value
4. Single-molecule Real-time Sequencing (SMRT)
  1. By Value
5. Nanopore Sequencing
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Expression Profiling Analysis
  1. By Value
3. Small RNA Sequencing
  1. By Value
4. De Novo Transcriptome Assembly
  1. By Value
5. Variant Calling and Transcriptome Epigenetics
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Research and Academia
  1. By Value
3. Hospitals and Clinics
  1. By Value
4. Pharmaceutical and Biotechnology Companies
  1. By Value
U.S.
1. By Product and Service
  1. Introduction
    1. Product and Service By Value
  2. Sample Preparation Products
    1. By Value
  3. Sequencing Platforms and Consumables
    1. By Value
  4. Sequencing Services
    1. By Value
  5. Data Analysis, Storage, and Management
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Sequencing by Synthesis (SBS)
    1. By Value
  3. Ion Semiconductor Sequencing
    1. By Value
  4. Single-molecule Real-time Sequencing (SMRT)
    1. By Value
  5. Nanopore Sequencing
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Expression Profiling Analysis
    1. By Value
  3. Small RNA Sequencing
    1. By Value
  4. De Novo Transcriptome Assembly
    1. By Value
  5. Variant Calling and Transcriptome Epigenetics
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Research and Academia
    1. By Value
  3. Hospitals and Clinics
    1. By Value
  4. Pharmaceutical and Biotechnology Companies
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product and Service
1. Introduction
  1. Product and Service By Value
2. Sample Preparation Products
  1. By Value
3. Sequencing Platforms and Consumables
  1. By Value
4. Sequencing Services
  1. By Value
5. Data Analysis, Storage, and Management
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sequencing by Synthesis (SBS)
  1. By Value
3. Ion Semiconductor Sequencing
  1. By Value
4. Single-molecule Real-time Sequencing (SMRT)
  1. By Value
5. Nanopore Sequencing
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Expression Profiling Analysis
  1. By Value
3. Small RNA Sequencing
  1. By Value
4. De Novo Transcriptome Assembly
  1. By Value
5. Variant Calling and Transcriptome Epigenetics
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Research and Academia
  1. By Value
3. Hospitals and Clinics
  1. By Value
4. Pharmaceutical and Biotechnology Companies
  1. By Value
U.K.
1. By Product and Service
  1. Introduction
    1. Product and Service By Value
  2. Sample Preparation Products
    1. By Value
  3. Sequencing Platforms and Consumables
    1. By Value
  4. Sequencing Services
    1. By Value
  5. Data Analysis, Storage, and Management
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Sequencing by Synthesis (SBS)
    1. By Value
  3. Ion Semiconductor Sequencing
    1. By Value
  4. Single-molecule Real-time Sequencing (SMRT)
    1. By Value
  5. Nanopore Sequencing
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Expression Profiling Analysis
    1. By Value
  3. Small RNA Sequencing
    1. By Value
  4. De Novo Transcriptome Assembly
    1. By Value
  5. Variant Calling and Transcriptome Epigenetics
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Research and Academia
    1. By Value
  3. Hospitals and Clinics
    1. By Value
  4. Pharmaceutical and Biotechnology Companies
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product and Service
1. Introduction
  1. Product and Service By Value
2. Sample Preparation Products
  1. By Value
3. Sequencing Platforms and Consumables
  1. By Value
4. Sequencing Services
  1. By Value
5. Data Analysis, Storage, and Management
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sequencing by Synthesis (SBS)
  1. By Value
3. Ion Semiconductor Sequencing
  1. By Value
4. Single-molecule Real-time Sequencing (SMRT)
  1. By Value
5. Nanopore Sequencing
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Expression Profiling Analysis
  1. By Value
3. Small RNA Sequencing
  1. By Value
4. De Novo Transcriptome Assembly
  1. By Value
5. Variant Calling and Transcriptome Epigenetics
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Research and Academia
  1. By Value
3. Hospitals and Clinics
  1. By Value
4. Pharmaceutical and Biotechnology Companies
  1. By Value
China
1. By Product and Service
  1. Introduction
    1. Product and Service By Value
  2. Sample Preparation Products
    1. By Value
  3. Sequencing Platforms and Consumables
    1. By Value
  4. Sequencing Services
    1. By Value
  5. Data Analysis, Storage, and Management
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Sequencing by Synthesis (SBS)
    1. By Value
  3. Ion Semiconductor Sequencing
    1. By Value
  4. Single-molecule Real-time Sequencing (SMRT)
    1. By Value
  5. Nanopore Sequencing
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Expression Profiling Analysis
    1. By Value
  3. Small RNA Sequencing
    1. By Value
  4. De Novo Transcriptome Assembly
    1. By Value
  5. Variant Calling and Transcriptome Epigenetics
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Research and Academia
    1. By Value
  3. Hospitals and Clinics
    1. By Value
  4. Pharmaceutical and Biotechnology Companies
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product and Service
1. Introduction
  1. Product and Service By Value
2. Sample Preparation Products
  1. By Value
3. Sequencing Platforms and Consumables
  1. By Value
4. Sequencing Services
  1. By Value
5. Data Analysis, Storage, and Management
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sequencing by Synthesis (SBS)
  1. By Value
3. Ion Semiconductor Sequencing
  1. By Value
4. Single-molecule Real-time Sequencing (SMRT)
  1. By Value
5. Nanopore Sequencing
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Expression Profiling Analysis
  1. By Value
3. Small RNA Sequencing
  1. By Value
4. De Novo Transcriptome Assembly
  1. By Value
5. Variant Calling and Transcriptome Epigenetics
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Research and Academia
  1. By Value
3. Hospitals and Clinics
  1. By Value
4. Pharmaceutical and Biotechnology Companies
  1. By Value
UAE
1. By Product and Service
  1. Introduction
    1. Product and Service By Value
  2. Sample Preparation Products
    1. By Value
  3. Sequencing Platforms and Consumables
    1. By Value
  4. Sequencing Services
    1. By Value
  5. Data Analysis, Storage, and Management
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Sequencing by Synthesis (SBS)
    1. By Value
  3. Ion Semiconductor Sequencing
    1. By Value
  4. Single-molecule Real-time Sequencing (SMRT)
    1. By Value
  5. Nanopore Sequencing
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Expression Profiling Analysis
    1. By Value
  3. Small RNA Sequencing
    1. By Value
  4. De Novo Transcriptome Assembly
    1. By Value
  5. Variant Calling and Transcriptome Epigenetics
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Research and Academia
    1. By Value
  3. Hospitals and Clinics
    1. By Value
  4. Pharmaceutical and Biotechnology Companies
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product and Service
1. Introduction
  1. Product and Service By Value
2. Sample Preparation Products
  1. By Value
3. Sequencing Platforms and Consumables
  1. By Value
4. Sequencing Services
  1. By Value
5. Data Analysis, Storage, and Management
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sequencing by Synthesis (SBS)
  1. By Value
3. Ion Semiconductor Sequencing
  1. By Value
4. Single-molecule Real-time Sequencing (SMRT)
  1. By Value
5. Nanopore Sequencing
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Expression Profiling Analysis
  1. By Value
3. Small RNA Sequencing
  1. By Value
4. De Novo Transcriptome Assembly
  1. By Value
5. Variant Calling and Transcriptome Epigenetics
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Research and Academia
  1. By Value
3. Hospitals and Clinics
  1. By Value
4. Pharmaceutical and Biotechnology Companies
  1. By Value
Brazil
1. By Product and Service
  1. Introduction
    1. Product and Service By Value
  2. Sample Preparation Products
    1. By Value
  3. Sequencing Platforms and Consumables
    1. By Value
  4. Sequencing Services
    1. By Value
  5. Data Analysis, Storage, and Management
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Sequencing by Synthesis (SBS)
    1. By Value
  3. Ion Semiconductor Sequencing
    1. By Value
  4. Single-molecule Real-time Sequencing (SMRT)
    1. By Value
  5. Nanopore Sequencing
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Expression Profiling Analysis
    1. By Value
  3. Small RNA Sequencing
    1. By Value
  4. De Novo Transcriptome Assembly
    1. By Value
  5. Variant Calling and Transcriptome Epigenetics
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Research and Academia
    1. By Value
  3. Hospitals and Clinics
    1. By Value
  4. Pharmaceutical and Biotechnology Companies
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

NGS-based RNA-Sequencing Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Illumina
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Thermo Fischer Scientific
Oxford Nanopore
Agilent Technologies, Inc
BGI
PerkinElmer Inc
QIAGEN
Eurofins Scientific
Hoffmann-La Roche Ltd
Takara Bio Inc
Tecan Genomics, Inc

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment